P. Duprez

Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.

J. Canon, Y. Humblet, V. D’Hondt, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)

Y. Humblet, M. Beauduin, M. Symann, 1990, Medical oncology and tumor pharmacotherapy.

Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: A dose escalation study of carboplatin

D. Rodenstein, Y. Humblet, M. Beauduin, 1989, Medical oncology and tumor pharmacotherapy.

180 Additional treatment does not improve the survival of locally advanced or metastatic NSCLC patients who responded after two courses of cisplatin (C), vindesin (V), mitomycin (M) chemotherapy

Y. Humblet, J. Jamart, L. Delaunois, 1997 .